Trade names Cefzil MedlinePlus a698022 Routes of
administration Oral CAS ID 92665-29-7 Protein binding 36% | AHFS/Drugs.com Monograph License data US FDA: Cefprozil Molar mass 389.427 g/mol Bioavailability 95% | |
 | ||
Pregnancy
category US: B (No risk in non-human studies) | ||
Cefprozil, sometimes spelled cefproxil and marketed under the trade name Cefzil,Cefproz.
Contents
Cefprozil is a second-generation cephalosporin type antibiotic. In Europe it is marketed using the trade names Procef and Cronocef. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.
Although there is a widely quoted cross-allergy risk of 10% between cephalosporins and penicillin, an article in the Journal of Family Practice has shown no increased risk for cross-allergy for cefprozil and several other second-generation or later cephalosporins.
Spectrum of bacterial susceptibility and resistance
Currently bacteria like Enterobacter aerogenes, Morganella morganii and Pseudomonas aeruginosa are resistant to cefprozil, while Salmonella enterica serotype Agona and streptococci are susceptible to cefprozil. Some bacteria like Brucella abortus, Moraxella catarrhalis and Streptococcus pneumoniae have developed resistance towards cefprozil in varying degrees. Detailed minimum inhibition concentration information is given by the Cefprozil Susceptibility and Resistance Data sheet.
Synthesis
Displacement of the allylic chloride in intermediate (1) with triphenylphosphine gives the phosphonium salt (2). This functionality is then converted to its ylide; condensation with acetaldehyde then leads to the vinyl derivative (3); deprotection then gives cefprozil. Semisynthetic oral cephalosporin consisting of ~90:10 Z/E isomeric mixture.